C143H309FN22O12 — CID 158375452
4-fluoro-1-propan-2-ylpiperidine;methane;tetrakis(2-methoxypropane);3-methyl-1-(1-methylpiperidin-4-yl)butan-1-one;1-methylpiperazine;N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine;1-methyl-4-(propan-2-yloxymethyl)piperidine;bis(1-methyl-3-(propan-2-yloxymethyl)pyrrolidine);1-methyl-N-propan-2-ylpiperidine-4-carboxamide;3-methyl-1-propan-2-ylpyrrolidine;1-methyl-N-propan-2-ylpyrrolidine-3-carboxamide;N-[(1-methylpyrrolidin-3-yl)methyl]propan-2-amine;1-(1-methylpyrrolidin-3-yl)propan-1-one;morpholine;piperazine;piperidine;1-propan-2-ylpyrrolidine (PubChem CID 158375452) has the molecular formula C143H309FN22O12 and a molecular weight of 2548.18 g/mol. Its IUPAC name is 4-fluoro-1-propan-2-ylpiperidine;methane;tetrakis(2-methoxypropane);3-methyl-1-(1-methylpiperidin-4-yl)butan-1-one;1-methylpiperazine;N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine;1-methyl-4-(propan-2-yloxymethyl)piperidine;bis(1-methyl-3-(propan-2-yloxymethyl)pyrrolidine);1-methyl-N-propan-2-ylpiperidine-4-carboxamide;3-methyl-1-propan-2-ylpyrrolidine;1-methyl-N-propan-2-ylpyrrolidine-3-carboxamide;N-[(1-methylpyrrolidin-3-yl)methyl]propan-2-amine;1-(1-methylpyrrolidin-3-yl)propan-1-one;morpholine;piperazine;piperidine;1-propan-2-ylpyrrolidine.
| Compound Name | 4-fluoro-1-propan-2-ylpiperidine;methane;tetrakis(2-methoxypropane);3-methyl-1-(1-methylpiperidin-4-yl)butan-1-one;1-methylpiperazine;N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine;1-methyl-4-(propan-2-yloxymethyl)piperidine;bis(1-methyl-3-(propan-2-yloxymethyl)pyrrolidine);1-methyl-N-propan-2-ylpiperidine-4-carboxamide;3-methyl-1-propan-2-ylpyrrolidine;1-methyl-N-propan-2-ylpyrrolidine-3-carboxamide;N-[(1-methylpyrrolidin-3-yl)methyl]propan-2-amine;1-(1-methylpyrrolidin-3-yl)propan-1-one;morpholine;piperazine;piperidine;1-propan-2-ylpyrrolidine |
|---|---|
| PubChem CID | 158375452 |
| Molecular Formula | C143H309FN22O12 |
| Molecular Weight | 2548.18 g/mol |
| Exact Mass | 2546.42 |
| IUPAC Name | 4-fluoro-1-propan-2-ylpiperidine;methane;tetrakis(2-methoxypropane);3-methyl-1-(1-methylpiperidin-4-yl)butan-1-one;1-methylpiperazine;N-[(1-methylpiperidin-4-yl)methyl]propan-2-amine;1-methyl-4-(propan-2-yloxymethyl)piperidine;bis(1-methyl-3-(propan-2-yloxymethyl)pyrrolidine);1-methyl-N-propan-2-ylpiperidine-4-carboxamide;3-methyl-1-propan-2-ylpyrrolidine;1-methyl-N-propan-2-ylpyrrolidine-3-carboxamide;N-[(1-methylpyrrolidin-3-yl)methyl]propan-2-amine;1-(1-methylpyrrolidin-3-yl)propan-1-one;morpholine;piperazine;piperidine;1-propan-2-ylpyrrolidine |
| SMILES | C.C1CCNCC1.C1CNCCN1.C1COCCN1.CC(C)CC(=O)C1CCN(C)CC1.CC(C)N1CCC(F)CC1.CC(C)N1CCCC1.CC(C)NC(=O)C1CCN(C)C1.CC(C)NC(=O)C1CCN(C)CC1.CC(C)NCC1CCN(C)C1.CC(C)NCC1CCN(C)CC1.CC(C)OCC1CCN(C)C1.CC(C)OCC1CCN(C)C1.CC(C)OCC1CCN(C)CC1.CC1CCN(C(C)C)C1.CCC(=O)C1CCN(C)C1.CN1CCNCC1.COC(C)C.COC(C)C.COC(C)C.COC(C)C |
| InChI | InChI=1S/C11H21NO.C10H20N2O.C10H22N2.C10H21NO.C9H18N2O.C9H20N2.2C9H19NO.C8H16FN.C8H15NO.C8H17N.C7H15N.C5H12N2.C5H11N.C4H10N2.C4H9NO.4C4H10O.CH4/c1-9(2)8-11(13)10-4-6-12(3)7-5-10;1-8(2)11-10(13)9-4-6-12(3)7-5-9;1-9(2)11-8-10-4-6-12(3)7-5-10;1-9(2)12-8-10-4-6-11(3)7-5-10;1-7(2)10-9(12)8-4-5-11(3)6-8;1-8(2)10-6-9-4-5-11(3)7-9;2*1-8(2)11-7-9-4-5-10(3)6-9;1-7(2)10-5-3-8(9)4-6-10;1-3-8(10)7-4-5-9(2)6-7;1-7(2)9-5-4-8(3)6-9;1-7(2)8-5-3-4-6-8;1-7-4-2-6-3-5-7;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-3-6-4-2-5-1;4*1-4(2)5-3;/h9-10H,4-8H2,1-3H3;8-9H,4-7H2,1-3H3,(H,11,13);9-11H,4-8H2,1-3H3;9-10H,4-8H2,1-3H3;7-8H,4-6H2,1-3H3,(H,10,12);8-10H,4-7H2,1-3H3;2*8-9H,4-7H2,1-3H3;7-8H,3-6H2,1-2H3;7H,3-6H2,1-2H3;7-8H,4-6H2,1-3H3;7H,3-6H2,1-2H3;6H,2-5H2,1H3;6H,1-5H2;5-6H,1-4H2;5H,1-4H2;4*4H,1-3H3;1H4 |
| InChIKey | GVDAXFYBSMJMRD-UHFFFAOYSA-N |
| XLogP | 19.84 |
| TPSA | 292.51 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 178 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2548.18 |
| LogP ≤ 5 | 19.84 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 32 |